Clinical Trials Browser

Phase 2 × Completed × fluciclovine F-18 × Clear all

NCT04158245 2025-09-22

18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies

Phase 2 Completed

9 enrolled 14 charts

Metastatic Castration-resistant Prostate Cancer

NCT04410367 2025-07-20

PURSUE

Phase 2 Completed

23 enrolled 10 charts

Brain Neoplasms, Disease

NCT03707184 2024-11-29

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

Phase 2 Completed

17 enrolled 8 charts

Prostatic Neoplasms

NCT03263780 2021-02-21

High Resolution PET-MRI Before Prostate Cancer HIFU

Phase 2 Completed

21 enrolled 12 charts

Prostatic Neoplasms

NCT03081884 2021-01-25

EDRN-FACBC

Phase 2 Completed

61 enrolled 6 charts

Urogenital Diseases, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT03515577 2020-10-14

PSMA vs AXUMIN

Phase 2 Completed

Prostatic Neoplasms

NCT02830880 2020-01-07

FACBC Prostate Therapy Response

Phase 2 Completed

7 enrolled 10 charts

Urogenital Diseases, Neoplasms, Prostatic Neoplasms

NCT01808222 2019-01-07

FACBC for Recurrent Prostate Cancer

Phase 2 Completed

25 enrolled 5 charts

Prostatic Neoplasms

NCT00562315 2016-06-21

FACBC PET/CT for Recurrent Prostate Cancer

Phase 2 Completed

128 enrolled 15 charts

Prostatic Neoplasms